Benitec Biopharma Inc

Benitec Biopharma Inc Stock

55.56P/E
€5.14MMarket capitalisation
-US$21.93Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.

Benitec Biopharma Inc is registered in the following country: United States of America (Exchange: USNASD).

Key metrics

Key metrics and master data for the Benitec Biopharma Inc stock.

Market capitalisation
€5.14M
P/E
55.56
P/B
0.07
P/S
56.18
P/CF
-0.01
Issued shares 28M Units

Return

Here you can see the performance of the Benitec Biopharma Inc stock.

PeriodPerfor­mance
1 Week-6.77 %
1 Month-4.79 %
3 Months-4.79 %
6 Months-8.81 %
1 Year-81.73 %
YTD+17.61 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Benitec Biopharma Inc share.

DateRatio
02.05.20181.019:1

Which ETF contains the Benitec Biopharma Inc stock?

The Benitec Biopharma Inc stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Benitec Biopharma Inc has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Benitec Biopharma Inc stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.